Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing **esomeprazole** (a proton pump inhibitor or PPI) and **amoxicillin** and **clarithromycin** (antibiotics). It is designed for the eradication of *Helicobacter pylori* (*H. pylori*).
## Primary Indications
Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The typical adult regimen is one dose pack taken twice daily for 10 days. Each dose pack usually contains:
* Esomeprazole 20 mg
* Amoxicillin 1000 mg
* Clarithromycin 500 mg
**Note:** Dosing may vary based on local resistance patterns and established treatment guidelines.
## Pediatric Dosing
Specific pediatric dosing for Sompraz HP is not well-established. Treatment of *H. pylori* in children should be guided by pediatric infectious disease specialists, using age- and weight-appropriate individual components if necessary.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment with this combination product. However, individual component guidelines should be considered.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of severe hypersensitivity to beta-lactams (e.g., penicillin).
* History of cholestatic jaundice or hepatic dysfunction associated with prior clarithromycin use.
* Concurrent use with colchicine, due to risk of toxicity.
* Concurrent use with cisapride, pimozide, quinidine, or simvastatin/lovastatin due to potential for QT prolongation and serious cardiac events with clarithromycin.
## Adverse Effects
Common adverse effects include diarrhea, nausea, headache, abdominal pain, taste disturbances (metallic taste), rash, and potential for allergic reactions. Clarithromycin can also cause QT prolongation.
## Key Drug Interactions
* **Esomeprazole:** May decrease absorption of drugs requiring acidic environment (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May increase levels of drugs metabolized by CYP2C19 (e.g., citalopram, clopidogrel).
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase serum concentrations of numerous drugs including statins (simvastatin, lovastatin), colchicine, warfarin, benzodiazepines, calcium channel blockers, and others, potentially leading to toxicity. Risk of QT prolongation with antiarrhythmics, antipsychotics, and other drugs.
* **Amoxicillin:** Generally fewer significant interactions. May decrease effectiveness of oral contraceptives.
## Monitoring
* Assess for signs and symptoms of *H. pylori* eradication (e.g., resolution of ulcer symptoms).
* Monitor for signs of hypersensitivity reactions.
* Monitor for diarrhea, which could indicate *Clostridioides difficile* infection.
* Evaluate for adverse effects associated with individual components.
## Clinical Pearls
* This combination therapy is a "triple therapy" regimen for *H. pylori* eradication.
* Patients should complete the full 10-day course as prescribed, even if symptoms improve earlier.
* Take esomeprazole before a meal. Amoxicillin and clarithromycin can be taken with or without food.
* If a dose is missed, take it as soon as remembered, unless it is almost time for the next dose. Do not double doses.
* Due to the potential for drug interactions, especially with clarithromycin, a thorough medication history is crucial.
---
*Disclaimer: This information is intended for clinical decision support and does not replace professional medical judgment or comprehensive prescribing information. Always consult the most current product monograph and relevant clinical guidelines before initiating therapy.*
